Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

274
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
274
Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

1.2K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

386
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
386
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

1.3K
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
1.3K
Liver Physiology01:30

Liver Physiology

3.8K
The liver, an essential organ in the human body, performs over 200 vital functions that can be broadly categorized into metabolic, hematological, endocrine regulation, and bile production.
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of  70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Chronic Viral Hepatitis With MASLD: Implications for Clinical and Patient-Reported Outcomes.

Journal of gastroenterology and hepatology·2026
Same author

Reducing the burden through early detection: Health-economic impact of gastrointestinal cancers in Saudi Arabia.

Journal of cancer policy·2026
Same author

Comparison of early-onset and average-onset colorectal cancer in Saudi Arabia: A multicenter retrospective cohort study.

Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association·2026
Same author

Novel Technologies for Gastrointestinal Cancer Detection: A Systematic Review and Meta-Analysis of Diagnostic Accuracy.

Clinical and translational gastroenterology·2026
Same author

A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society·2026
Same author

Predictors and outcomes of hepatic decompensation following transarterial locoregional therapy in hepatocellular carcinoma.

Scientific reports·2026

Related Experiment Video

Updated: May 5, 2026

Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
06:11

Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique

Published on: May 2, 2025

787

Evaluation of abnormal liver tests.

Tinsay A Woreta1, Saleh A Alqahtani

  • 1Division of Gastroenterology and Hepatology, The Johns Hopkins Hospital, 1830 East Monument Street, Suite 428, Baltimore, MD 21287, USA.

The Medical Clinics of North America
|November 26, 2013
PubMed
Summary
This summary is machine-generated.

Serum biochemical tests detect liver injury early. These tests, alongside noninvasive fibrosis assessments, aid in diagnosing and managing chronic liver disease, improving patient prognosis.

Keywords:
Alkaline phosphataseAminotransferasesBilirubin metabolismCholestasisHepatocellular injury

More Related Videos

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

11.0K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.0K

Related Experiment Videos

Last Updated: May 5, 2026

Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique
06:11

Laparoscopic Anatomical Resection of the Right Anterior Lobe Based on the Laennec Capsule Technique

Published on: May 2, 2025

787
Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube
06:12

Inducing Acute Liver Injury in Rats via Carbon Tetrachloride CCl4 Exposure Through an Orogastric Tube

Published on: April 28, 2020

11.0K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.0K

Area of Science:

  • Hepatology
  • Clinical Biochemistry

Background:

  • Serum biochemical tests are crucial for detecting liver injury, encompassing hepatocellular injury markers (aminotransferases, alkaline phosphatases), liver metabolism (total bilirubin), and synthetic function (albumin, prothrombin time).
  • Noninvasive tests for liver fibrosis show promise for diagnosing and predicting outcomes in chronic liver disease patients.

Purpose of the Study:

  • To review the utility of serum biochemical tests and noninvasive fibrosis assessments in the diagnosis and prognosis of liver diseases.
  • To highlight the comprehensive approach including history, physical examination, laboratory, and imaging tests for establishing hepatobiliary disease causes.

Main Methods:

  • Review of established serum biochemical markers for liver injury.
  • Discussion of noninvasive testing modalities for liver fibrosis.
  • Emphasis on integrating clinical assessment with laboratory and imaging data.

Main Results:

  • Routine serum biochemical tests enable early detection of acute and chronic liver injury.
  • Specific markers identify hepatocellular injury, metabolic function, and synthetic capacity.
  • Noninvasive fibrosis tests offer valuable diagnostic and prognostic information.

Conclusions:

  • Serum biochemical tests are fundamental for early liver injury detection.
  • A combination of clinical evaluation, laboratory tests, and imaging is essential for comprehensive hepatobiliary disease diagnosis.
  • Noninvasive fibrosis assessments enhance the management of chronic liver disease.